共 50 条
- [32] PROGNOSTIC FACTORS (PF) IN METASTATIC BREAST-CANCER (MBC) TREATED WITH COMBINATION CHEMO-IMMUNOTHERAPY (CI) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 371 - 371
- [35] SERUM FERRITIN AS A MARKER OF THERAPEUTIC RESPONSE IN STAGE-III AND STAGE-IV BREAST-CANCER EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1990, 16 (01): : 22 - 27
- [36] A CONTROLLED CLINICAL-TRIAL ON ADJUVANT THERAPY BY PREOPERATIVE IRRADIATION OR POSTOPERATIVE CYCLOPHOSPHAMIDE IN BREAST-CANCER ARCHIV FUR GESCHWULSTFORSCHUNG, 1980, 50 (05): : 468 - 479
- [38] COMBINATION OF LEVAMISOLE IMMUNOTHERAPY AND POLYCHEMOTHERAPY IN ADVANCED BREAST-CANCER CANCER TREATMENT REPORTS, 1980, 64 (01): : 65 - 72
- [39] STAGE-IV BREAST-CANCER - CLINICAL COURSE AND SURVIVAL OF PATIENTS WITH OSSEOUS VERSUS EXTRAOSSEOUS METASTASES AT INITIAL DIAGNOSIS AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (06): : 618 - 622